InvestorsHub Logo
Followers 3
Posts 155
Boards Moderated 0
Alias Born 09/24/2018

Re: Jamaalish post# 183837

Thursday, 03/28/2019 7:38:22 AM

Thursday, March 28, 2019 7:38:22 AM

Post# of 425942
CELG is also a good example in that most of their growth was while they were GIA. That stock went from $5-$10 to over $120 before it settled back down to $70 and was offered a BO at $90. If I’m not mistaken the market cap for CELG when it was as around $100/share was around $100 billion. The 2 differences I see between us and CELG is 1. CELG has more than 1 drug and 2. Vascepa is a much bigger blockbuster than anything CELG has.

GIA for the next 18-24 months, enjoy one hell of a price rise and then sell out for a nice premium. Not a bad outcome if you ask me, but long term GIA might be even better.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News